{"id":"https://openalex.org/W2079512442","doi":"https://doi.org/10.1177/0269881108099418","title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","display_name":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","alternate_titles":[],"publication_year":2008,"publication_date":"2008-12-12","ids":{"openalex":"https://openalex.org/W2079512442","doi":"https://doi.org/10.1177/0269881108099418","mag":"2079512442","pmid":"https://pubmed.ncbi.nlm.nih.gov/19074536"},"language":"en","primary_location":{"id":"doi:10.1177/0269881108099418","doi":"https://doi.org/10.1177/0269881108099418","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881108099418","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2079512442"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061926369","display_name":"Eduard Vieta","orcid":"https://orcid.org/0000-0002-0548-0053","observed_orcids":["https://orcid.org/0000-0002-0548-0053"]},"institutions":[{"id":"https://openalex.org/I4210090703","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","ror":"https://ror.org/009byq155","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210090703","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"E. Vieta","raw_affiliation_strings":["Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain,","institution_ids":["https://openalex.org/I4210090703","https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089494614","display_name":"Tanya S. Ramey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Ramey","raw_affiliation_strings":["Pfizer Global Research and Development, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056060868","display_name":"David Keller","orcid":"https://orcid.org/0000-0001-6780-3869","observed_orcids":["https://orcid.org/0000-0001-6780-3869"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Keller","raw_affiliation_strings":["Pfizer Global Research and Development, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029267492","display_name":"PA English","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"PA English","raw_affiliation_strings":["La Jolla Laboratories, Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Jolla Laboratories, Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066996227","display_name":"A D Loebel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"AD Loebel","raw_affiliation_strings":["Dainippon Sumitomo Pharma America, Inc, Fort Lee, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dainippon Sumitomo Pharma America, Inc, Fort Lee, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111859786","display_name":"J. J. Miceli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Miceli","raw_affiliation_strings":["Pfizer Global Research and Development, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5061926369"],"corresponding_institution_ids":["https://openalex.org/I4210090703","https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":5.933,"has_fulltext":false,"cited_by_count":80,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96221995,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"24","issue":"4","first_page":"547","last_page":"558"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":1.0},{"id":"https://openalex.org/keywords/acute-mania","display_name":"acute mania","score":0.843999981880188},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9879999756813049},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antipsychotic-monotherapy","display_name":"antipsychotic monotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7400000095367432},{"id":"https://openalex.org/keywords/remission-maintenance","display_name":"remission maintenance","score":0.6610000133514404},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7730000019073486},{"id":"https://openalex.org/keywords/movement-disorders","display_name":"movement disorders","score":0.8339999914169312},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.8948027491569519},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.8393965363502502},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.7058650255203247},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5872248411178589},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5575799345970154},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4891062378883362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48496460914611816},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3974657654762268},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.35159236192703247},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.33776986598968506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3024466037750244},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.29455137252807617},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2538178563117981},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.12075993418693542},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007194","descriptor_name":"India","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012426","descriptor_name":"Russia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881108099418","doi":"https://doi.org/10.1177/0269881108099418","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881108099418","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:19074536","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19074536","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W6806859","https://openalex.org/W871677187","https://openalex.org/W1956321811","https://openalex.org/W1964973130","https://openalex.org/W1968912840","https://openalex.org/W1971680101","https://openalex.org/W1976706794","https://openalex.org/W1977137219","https://openalex.org/W1988730265","https://openalex.org/W2005567237","https://openalex.org/W2007865301","https://openalex.org/W2012355684","https://openalex.org/W2014590512","https://openalex.org/W2022320465","https://openalex.org/W2024077111","https://openalex.org/W2029941916","https://openalex.org/W2037034236","https://openalex.org/W2039055313","https://openalex.org/W2058211318","https://openalex.org/W2061276728","https://openalex.org/W2092091703","https://openalex.org/W2095635647","https://openalex.org/W2099549036","https://openalex.org/W2106384858","https://openalex.org/W2109442247","https://openalex.org/W2111105929","https://openalex.org/W2124969157","https://openalex.org/W2127613088","https://openalex.org/W2135941823","https://openalex.org/W2328216037","https://openalex.org/W2416781210","https://openalex.org/W4242811026","https://openalex.org/W4247787565"],"related_works":["https://openalex.org/W2099549036","https://openalex.org/W1971680101","https://openalex.org/W2014590512","https://openalex.org/W2169679343","https://openalex.org/W2029941916","https://openalex.org/W2037034236","https://openalex.org/W2006464393","https://openalex.org/W2351162697","https://openalex.org/W2127663280","https://openalex.org/W2056325582"],"abstract_inverted_index":{"This":[0],"12-week,":[1],"double-blind,":[2],"two-part":[3],"study":[4],"in":[5],"438":[6],"adults":[7],"with":[8,13,23],"bipolar-associated":[9],"acute":[10,202],"mania":[11],"began":[12],"a":[14,214],"3-week":[15,177],"period":[16],"comparing":[17],"ziprasidone":[18,39,69,104,112,124,141,151,171,212],"(80-160":[19],"mg/day)":[20,26,126],"and":[21,40,88,93,103,142,160,172,178,184,187,190],"placebo":[22,45,102,114],"haloperidol":[24,41,67,92,128,149,173,208],"(8-30":[25],"as":[27],"active":[28,99],"reference.":[29],"Changes":[30],"from":[31,46,59,81],"baseline":[32,60,82],"Mania":[33],"Rating":[34],"Scale":[35],"(MRS)":[36],"scores":[37],"for":[38,66,90,123,138,174,201],"were":[42,132,181],"superior":[43,215],"to":[44,52,115,197],"day":[47],"2":[48],"(P":[49,55,70,96],"=":[50],"0.001)":[51],"week":[53,62,74],"3":[54,63],"<":[56],"0.001);":[57],"change":[58],"at":[61],"was":[64,85,121,195],"greater":[65,210],"than":[68,150],"<or=":[71,97],"0.001).":[72],"At":[73],"3,":[75],"the":[76,108,135,175],"response":[77],"rate":[78],"(>or=50%":[79],"decrease":[80],"MRS":[83],"score)":[84],"36.9,":[86],"54.7":[87],"20.5%":[89],"ziprasidone,":[91],"placebo,":[94],"respectively":[95],"0.05,":[98],"treatments":[100],"versus":[101,105,158],"haloperidol).":[106],"In":[107],"9-week":[109,179],"extension":[110,180],"phase,":[111],"replaced":[113],"examine":[116],"tolerability.":[117],"Maintenance":[118],"of":[119,165,170,204],"improvement":[120],"evaluated":[122],"(40-160":[125],"or":[127],"(4-30":[129],"mg/day).":[130],"Responses":[131],"maintained":[133],"through":[134],"last":[136],"visit":[137],"88.1%":[139],"receiving":[140,144,148],"96.3%":[143],"haloperidol.":[145],"More":[146],"patients":[147],"discontinued":[152],"treatment":[153,203],"during":[154],"weeks":[155],"4-12":[156],"(21.1%":[157],"9.6%)":[159],"had":[161],"significantly":[162],"higher":[163],"rates":[164],"movement":[166],"disorders.":[167],"Mean":[168],"doses":[169],"first":[176],"116.2":[182],"mg/day":[183,186,189],"121.4":[185],"16.0":[188],"16.1":[191],"mg/day,":[192],"respectively.":[193],"Ziprasidone":[194],"shown":[196],"be":[198],"effective":[199],"monotherapy":[200],"bipolar":[205],"mania.":[206],"Although":[207],"showed":[209,213],"efficacy,":[211],"tolerability":[216],"profile.":[217]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2079512442","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
